PropertyValue
?:abstract
  • To better understand humoral immunity following SARS-CoV-2 infection, 114 hospitalised COVID-19 patients with antibody monitored over 8 weeks from symptom onset were retrospectively investigated. A total of 445 serum samples were assessed via chemiluminescence immunoassay. Positive rate of virus-specific IgM reached up to over 80% from the second week to the eighth week after symptom onset, then declined quickly to below 30% in the twelfth week. Concentrations of IgG remained high for at least 3 months before subsequently declining. As compared with the non-severe group, serum IgM level from week 3 to week 8 was significantly higher among the patients with severe clinical symptoms (P = 0.012) but not IgG (P = 0.053). Serum IgM level from week 3 to week 8 was correlated with positive virus RNA test (r = 0.201, P = 0.044), albumin level (r = −0.295, P = 0.003), lactic dehydrogenase (LDH) level (r = 0.292, P = 0.003), alkaline phosphatase (ALP) level (r = 0.254, P = 0.010), C-reactive protein (CRP) level (r = 0.281, P = 0.004) during the same course, while serum IgG level was correlated with age (r = 0.207, P = 0.038). This presented results provide insight into duration of SARS-CoV-2 antibodies and interaction between the virus and host systems.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.intimp.2020.107271
?:doi
?:journal
  • Int_Immunopharmacol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/db2e3fe2d024314381963593790282871c772803.json; document_parses/pdf_json/45bf985b8a1c746a6b9b354f13b6ed6e6af2d16a.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7724312.xml.json
?:pmcid
?:pmid
?:pmid
  • 33310664.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
?:type
?:year
  • 2020-12-09

Metadata

Anon_0  
expand all